Endovascular treatment of acute ischemic stroke in patients with pre-morbid disability: a meta-analysis
- 14 March 2022
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 15 (4) , 343-349
Abstract
Background Trials of endovascular thrombectomy (EVT) for acute stroke have excluded patients with pre-morbid disability. Observational studies may help inform consideration of EVT in this population. We aimed to assess the effectiveness and safety of EVT in patients with pre-morbid disability. Methods According to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched MEDLINE and Embase for studies describing outcomes in patients with pre-morbid disability (modified Rankin Scale (mRS) 2–5), treated with EVT or medical management (MM). Random-effects meta-analysis was used to pool outcomes including 90-day return to baseline mRS, symptomatic intracerebral hemorrhage (sICH), and 90-day mortality. Results We analyzed 14 studies of patients with pre-morbid disability (mRS 2–5, 1373 EVT and 253 MM). The rate of return to baseline mRS was 30.0% (95% CI 25.3% to 34.7%) in patients treated with EVT. Compared with medical therapy, EVT was associated with a higher likelihood of return to baseline mRS (OR 2.37, 95% CI 1.39 to 4.04) and a trend towards lower mortality (OR 0.68, 95% CI 0.46 to 1.02), with similar odds of sICH (OR 1.01, 95% CI 0.49 to 2.08). In studies comparing patients with versus without pre-morbid disability treated with EVT, similar results were found except that pre-morbid disability, when defined more strictly as mRS 3–5, was associated with mortality (OR 3.49, pConclusion In eligible patients with pre-morbid disability, observational studies suggest that EVT carries a higher chance of return to baseline mRS compared with patients treated with MM or without pre-morbid disability, although with higher mortality than patients without pre-morbid disability. These findings argue against the routine exclusion of such patients from EVT and merit validation with randomized trials.Keywords
This publication has 34 references indexed in Scilit:
- Increased Risk for Unfavorable Outcome in Patients with Pre-Existing Disability Undergoing Endovascular TherapyJournal of Stroke and Cerebrovascular Diseases, 2018
- Pre-Stroke Modified Rankin Scale: Evaluation of Validity, Prognostic Accuracy, and Association with TreatmentFrontiers in Neurology, 2017
- Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke UnitJournal of Thrombosis and Thrombolysis, 2016
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin ScaleStroke, 2015
- The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird methodBMC Medical Research Methodology, 2014
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010The Lancet, 2014
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Evaluation of the Quality of Prognosis Studies in Systematic ReviewsAnnals of Internal Medicine, 2006
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000